[Bullous cutaneous mastocytosis revealed by acute disease secondary to morphine administration]

L Leblanc1, J V de Monléon, V Faber

  • 1Service de dermatologie, centre hospitalier universitaire de Dijon, 10, boulevard du Maréchal-de-Lattre-de-Tassigny, 21034 Dijon, France.

Insights

Bullous cutaneous mastocytosis is a rare pediatric skin condition. Early diagnosis and treatment are crucial for managing severe symptoms and ensuring normal development.

Area of Science:

  • Pediatric Dermatology
  • Hematology

Background:

  • Mastocytosis presents in children with three clinical forms, the rarest being the diffuse or bullous type.
  • Bullous cutaneous mastocytosis is an uncommon pediatric dermatological condition.

Observation:

  • An infant presented with diffuse erythema and a vesicle rash from one month of age.
  • At four months, severe discomfort post-morphine administration prompted diagnosis of bullous cutaneous mastocytosis.
  • Histologic examination confirmed the diagnosis of bullous cutaneous mastocytosis.

Findings:

  • The infant's severe clinical presentation necessitated intravenous corticosteroid and antihistamine therapy.
  • Histological confirmation underscored the diagnosis of bullous cutaneous mastocytosis.

Implications:

  • Bullous cutaneous mastocytosis, though rare in children, warrants consideration due to potential severe complications and therapeutic risks.
  • Prompt and appropriate management, including potential intravenous corticosteroid therapy, can lead to normal development and disease resolution before adolescence.
Abstract

Related Concept Videos